- ABRAHAMSON A: Wheeler used supplement. Sports (2001).
- HALLER CA, BENOWITZ NL:Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl. J. Med. (2000) 343:1833–1838.
- •Reviews adverse events reported to the US FDA between 1997 and 1999.
- CAREY B: Risks of ephedra usage in spotlight. Los Angeles Times, Health, 27th August (2001).
- WILD-MATTHEWS,SCHAEFER-MUNOZ S: Judge overturns ban on ephedra, roils FDA policy. Wall Street Journal, 15 April (2005).
- MAGLIONE MA, MIOTTO K, IGUCHI M, JUN VIG L, MORTON SC, SHEKELLE PG: Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events. Am. J. Psychiatry (2005) 162:189–191.
- HARDMAN JG, LIMBIRD LE, GILMAN A: Goodman and Cilman's The Pharmacologic Bash of Disease, 10th ed. McGraw-Hill, New York, NY (2001).
- BURNHAM TH, NOVAK KK, BELL WL, SCHWEAIN SL: Ephedrine. In: Drug Facts and Comparisons. Facts and Comparisons, St Louis, MO (2002).
- KARCH SB: Ma huang and the ephedra alkaloids. In: Toxicology and Clinical Pharmacology of Herbal Products Cupp MJ (Ed.), Humana Press Inc, Totowa, NJ (2000).
- LEUNG AY, FOSTERS: Ephedra. In: Encyclopedia of Common Natural Ingredients Used in Foods, Drugs, and Cosmetics. Leung AY, Foster S (Ed.), John Wiley, New York, NY (1996).
- MCKENNA DJ, JONES K, HUGHES K: Botanical Medicines: The Desk Reference for Major Herbal Supplements. The Haworth Press, New York, NY (2002).
- EVANS WC: Trease and Evans' Pharmacognosy, 13th ed. WB Saunders, London (1989).
- ROTHMAN RB, VU N, PARTILLA JS et al: In vitro characterization of ephedrine-related sterioisomers at biogenic amine transporters and the receptorome reveals selective actions as norephinephrine transporter substrates. JPET(2003) 307:138–145.
- •Latest research on the mechanism of action of ephedra.
- ROBINSON TE, BECKER JB: Enduring changes in brain and behavior produced by chronic amphetamine administration. A review and evaluation of animal models of amphetamine psychosis. Brain Res. (1986) 396:157–198.
- MARTIN WR, SLOAN JW, SAPIRA JD, JASINSKI DR: Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in marl. Clin. Pharmacol Ther.(1971) 12:245–258.
- HERRIDGE CF, BROOK MF: Ephedrine psychosis. Br. Med. J. (1968) 2:160.
- ROXANAS MG, SPALDING J: Ephedrine abuse psychosis. Med. J. Aust. (1977) 2:639–640.
- WHITEHOUSE AM, DUNCAN JM: Ephedrine psychosis rediscovered. Br. J. Psychiatry (1987) 150:258–261.
- ESCOBAR JI, KARNO M: Chronic hallucinosis from nasal drops. JAMA (1982) 247:1859–1860.
- TINSLEY JA, WATKINS DD: Over-the-counter stimulants: abuse and addiction. Mayo Clin. Proc. (1998) 73:977–982.
- KANE FJ JR, FLORENZANO R: Psychosis accompanying use of bronchodilator compound. JAMA (1971) 215:2116.
- CAP WELL RR: Ephedrine-induced mania from an herbal diet supplement. Am. J. Psychiatry (1995) 152:647.
- DOYLE H, KARGIN M:Herbal stimulant containing ephedrine has also caused psychosis. BE Med. J. (1996) 313:756.
- JACOBS KM, HIRSCH KA: Psychiatric complications of Ma-huang. Psychosomatics (2000) 41:58–62.
- BOERTH, JM, CALEY, CF: Possible case of mania associated with ma-huang. Pharmacotherapy (2003) 23(3):380–383.
- SHEKELLE PG, HARDY ML, MORTON SC et al: Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA (2003) 289:1537-1545••A systematic review and meta-analysisof controlled clinical trails of ephedra.
- US DEPARTMENT OF HEALTH AND HUMAN SERVICES AND OFFICE OF INSPECTOR GENERAL:Adverse event reporting for dietary supplements: an inadequate safety valve.Publication OEI-01-00-00180. Washington, DC (2001).
Expert Opinion on Drug Safety
Volume 4, 2005 - Issue 5